Research / AVGO / Fundamental state Inspectable configuration
State dimensions Filing 0001730168-20-000164 General Corporate
Debt relative to revenue 78th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.debt_to_revenue
755.13% · OPTIONAL · VALID
Capex intensity 13th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.80% · OPTIONAL · VALID
Operating cash generation 88th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
54.60% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
5.55% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 56th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
18.57% · OPTIONAL · VALID
Gross margin 100th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.gross_margin
56.97% · CORE · VALID
Operating margin 56th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.operating_margin
17.32% · CORE · VALID
R&D intensity 67th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
21.10% · OPTIONAL · VALID
SBC intensity 33th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
7.99% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 23 states Self-history eligible
Feb 3, 2019 0/8 normalized Level 3 May 5, 2019 0/9 normalized Level 3 Aug 4, 2019 0/9 normalized Level 3 Nov 3, 2019 0/9 normalized Level 3 Feb 2, 2020 0/9 normalized Level 3 May 3, 2020 6/9 normalized Level 3 Aug 2, 2020 8/9 normalized Level 3 Nov 1, 2020 8/9 normalized Level 3 Jan 31, 2021 8/9 normalized Level 3 May 2, 2021 9/9 normalized Level 3 Aug 1, 2021 9/9 normalized Level 3 Oct 31, 2021 9/9 normalized Level 3 Jan 30, 2022 9/9 normalized Level 3 May 1, 2022 9/9 normalized Level 3 Jul 31, 2022 9/9 normalized Level 3 Oct 30, 2022 8/8 normalized Level 3 Jan 29, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 30, 2023 8/8 normalized Level 3 Aug 2, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 797.77%
Current 755.13%
Delta -42.64% Capex Intensity Decreased
Previous 2.58%
Current 1.80%
Delta -0.77% Cash Generation Decreased
Previous 55.96%
Current 54.60%
Delta -1.36% Growth Increased
Previous 4.08%
Current 5.55%
Delta 1.47% Inventory Pressure Increased
Previous 16.60%
Current 18.57%
Delta 1.97% Margin Increased
Previous 55.54%
Current 56.97%
Delta 1.43% Profitability Increased
Previous 13.34%
Current 17.32%
Delta 3.98% R And D Intensity Decreased
Previous 22.10%
Current 21.10%
Delta -1.00% Sbc Intensity Decreased
Previous 9.00%
Current 7.99%
Delta -1.02% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.